STERIS plc (STE) Income Statement
STE FY2026 at a glance
Fiscal year ended March 31, 2026 · U.S. dollarsSTE revenue and net income
Where STE's revenue goes
FY2026Each bar shows an amount and its share of revenue. STE kept 13.2% of revenue as net income.
STE profit margins
STE growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +8.7% | +9.4% | +13.8% | +10.2% |
| Gross profit | +9.3% | +9.9% | +14.4% | +11.4% |
| Operating income | +27.1% | +11.7% | +15.0% | +17.9% |
| Net income | +27.7% | +94.3% | +14.6% | +21.6% |
| EPS (diluted) | +10.2% | +7.4% | +10.6% | +11.8% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
STE quarterly EPS vs estimates
Steris beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 4, 2026 (estimate $2.67).
STE income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | $2.62B | $2.61B |
| Cost of revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B | $1.53B | $1.59B |
| Gross profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B | $1.09B | $1.03B |
| Research & development | $112.9M | $107.6M | $103.7M | $98.5M | $86.7M | $66.3M | $65.5M | $63.0M | $60.8M | $59.4M |
| Sales, general & admin | $1.41B | $1.32B | $1.23B | $1.07B | $1.12B | $731.3M | $716.7M | $669.9M | $615.8M | $652.0M |
| Total operating expenses | $1.52B | $1.54B | $1.38B | $1.19B | $1.41B | $794.7M | $783.0M | $764.0M | $692.9M | $800.0M |
| Operating income | $1.10B | $866.6M | $836.1M | $791.1M | $477.8M | $548.4M | $537.0M | $411.0M | $399.9M | $226.2M |
| Interest income | $9.8M | $8.4M | $11.0M | $110.8M | $6.3M | $6.3M | $38.3M | $42.0M | $44.9M | $41.6M |
| Interest expense | $60.7M | $86.3M | $144.4M | $110.8M | $89.5M | $37.2M | $40.3M | $45.0M | $50.6M | $44.5M |
| Income before taxes | $1.05B | $796.2M | $702.8M | $680.3M | $366.8M | $517.5M | $498.8M | $369.0M | $355.0M | $184.6M |
| Income taxes | $262.2M | $184.7M | $149.5M | $124.1M | $82.3M | $120.7M | $90.9M | $64.3M | $63.4M | $74.0M |
| Net income | $785.1M | $614.6M | $378.2M | $107.0M | $243.9M | $397.4M | $407.7M | $304.1M | $290.9M | $110.0M |
| EBITDA | $1.59B | $1.36B | $1.41B | $1.36B | $1.01B | $774.0M | $736.3M | $640.0M | $583.9M | $417.3M |
| EPS (diluted) | $10.17 | $9.23 | $8.87 | $8.21 | $7.91 | $6.15 | $5.64 | $4.89 | $4.15 | $3.77 |
| Gross margin | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% |
| Operating margin | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% | 15.3% | 8.7% |
| Net margin | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B | $1.28B | $1.12B | $1.30B | $1.24B |
| Cost of revenue | $808.5M | $891.3M | $840.6M | $814.4M | $763.1M | $839.3M | $760.2M | $750.1M | $707.1M | $667.6M | $737.7M | $692.0M |
| Gross profit | $684.2M | $697.1M | $655.5M | $645.9M | $628.0M | $641.2M | $610.3M | $578.8M | $572.4M | $448.6M | $560.0M | $546.2M |
| Research & development | $28.6M | $28.8M | $29.5M | $28.2M | $26.4M | $27.7M | $27.4M | $27.0M | $25.6M | $25.2M | $25.3M | $26.3M |
| Sales, general & admin | $369.7M | $351.8M | $352.3M | $349.7M | $353.8M | $332.0M | $335.4M | $329.3M | $335.6M | $152.1M | $360.5M | $380.7M |
| Total operating expenses | $398.4M | $380.6M | $382.3M | $380.1M | $382.0M | $425.1M | $365.0M | $359.1M | $386.9M | $203.4M | $333.6M | $354.7M |
| Operating income | $285.8M | $316.8M | $271.0M | $268.0M | $246.0M | $216.2M | $245.3M | $219.7M | $185.5M | $245.2M | $226.5M | $191.6M |
| Interest income | $3.1M | $2.8M | $12.0M | $2.4M | $1.8M | $3.5M | $2.4M | $1.1M | $1.3M | $6.3M | $2.1M | $35.7M |
| Interest expense | $15.8M | $15.1M | $14.8M | $14.9M | $15.9M | $17.1M | $19.1M | $19.7M | $30.4M | $36.1M | $38.9M | $36.9M |
| Income before taxes | $273.5M | $304.5M | $257.8M | $253.1M | $231.9M | $197.3M | $228.7M | $194.9M | $175.2M | $215.5M | $189.6M | $155.9M |
| Income taxes | $72.5M | $84.2M | $63.5M | $60.6M | $53.9M | $50.5M | $55.4M | $43.5M | $35.3M | $43.3M | $41.0M | $35.1M |
| Net income | $200.1M | $220.3M | $192.8M | $191.9M | $177.4M | $145.7M | $173.5M | $150.0M | $145.4M | −$1.4M | $140.7M | $115.3M |
| EBITDA | $406.1M | $443.0M | $391.2M | $389.7M | $367.2M | $336.8M | $373.8M | $329.8M | $318.3M | $386.0M | $369.2M | $345.0M |
| EPS (diluted) | $2.59 | $2.83 | $2.53 | $2.47 | $2.34 | $2.74 | $2.32 | $2.14 | $2.03 | $2.58 | $2.22 | $2.07 |
| Gross margin | 45.8% | 43.9% | 43.8% | 44.2% | 45.1% | 43.3% | 44.5% | 43.6% | 44.7% | 40.2% | 43.2% | 44.1% |
| Operating margin | 19.1% | 19.9% | 18.1% | 18.4% | 17.7% | 14.6% | 17.9% | 16.5% | 14.5% | 22.0% | 17.5% | 15.5% |
| Net margin | 13.4% | 13.9% | 12.9% | 13.1% | 12.8% | 9.8% | 12.7% | 11.3% | 11.4% | −0.1% | 10.8% | 9.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in STE's financial statements (latest annual report filed May 29, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
STE financial results
In fiscal year 2026 (ended March 31, 2026), Steris reported revenue of $5.9 billion, up 8.7% from the year before. It had net income of $785.1 million (up 27.7%), a net profit margin of 13.2%. Diluted earnings per share came to $10.17. Over five years revenue grew at an average rate of 13.8% a year.
See the STE stock overview for the latest quote and news, or the STE chart for price history and technical indicators.
STE income statement FAQ
What is Steris's annual revenue?
Steris reported total revenue of $5.9 billion for fiscal year 2026, which ended on March 31, 2026. That was up 8.7% from $5.5 billion the previous year.
Is Steris profitable?
Yes. Steris reported net income of $785.1 million in fiscal 2026, a net profit margin of 13.2%; its operating margin was 18.6%.
What is Steris's gross margin?
Steris's gross margin was 44.2% in fiscal 2026: for every $100 of revenue, Steris kept $44 after the direct cost of its products and services.
How much does Steris spend on research and development?
Steris spent $112.9 million on research and development in fiscal 2026, 1.9% of revenue.
How fast is Steris growing?
Revenue grew 13.8% a year on average over the last five fiscal years, from $3.1 billion to $5.9 billion.
What are Steris's earnings per share?
Steris earned $10.17 per diluted share in fiscal 2026, compared with $9.23 a year earlier.
When will Steris report its next earnings?
Steris is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes.
When does Steris's fiscal year end?
Steris's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026 and was filed on May 29, 2026.